导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.12% | 45/76 |
| 近一周 | -2.23% | 16/86 |
| 近一月 | -2.54% | 17/85 |
| 近一季 | -3.40% | 25/85 |
| 近半年 | 5.90% | 41/78 |
| 近一年 | 3.22% | 47/74 |
| 近两年 | 20.24% | 60/70 |
| 近三年 | 48.23% | 36/62 |
| 成立以来 | 329.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.17% 47/76 |
11.31% 50/85 |
- - |
- - |
| 2025 | 12.13% 67/76 |
-0.30% 30/74 |
8.05% 52/74 |
2.52% 71/74 |
1.54% 25/76 |
| 2024 | 21.66% 32/75 |
12.36% 7/67 |
1.92% 47/72 |
1.56% 51/74 |
4.61% 24/75 |
| 2023 | 22.22% 8/72 |
3.09% 27/57 |
11.87% 18/64 |
-2.29% 18/68 |
8.46% 26/72 |
| 2022 | -17.65% 18/46 |
-11.54% 19/43 |
-10.87% 28/45 |
-1.06% 9/45 |
5.57% 22/46 |
| 2021 | 11.56% 9/43 |
1.76% 145/312 |
5.81% 125/328 |
0.29% 84/358 |
3.30% 10/43 |
| 2020 | 12.06% 27/41 |
-14.66% 188/280 |
20.40% 96/295 |
4.15% 105/299 |
4.71% 203/305 |
| 2019 | 29.27% 9/35 |
12.13% 85/258 |
6.88% 10/268 |
2.17% 86/253 |
5.57% 145/266 |
| 2018 | 2.84% 1/31 |
- - |
- - |
- - |
-11.88% 136/241 |
| 2017 | 19.38% 23/30 |
- - |
- - |
- - |
- - |
| 2016 | 6.84% 7/31 |
- - |
- - |
- - |
- - |
| 2015 | 15.58% 1/30 |
- - |
- - |
- - |
- - |
| 2014 | 7.60% 32/99 |
- - |
- - |
- - |
- - |
| 2013 | 29.28% 6/70 |
- - |
- - |
- - |
- - |
| 2012 | 10.13% 29/51 |
- - |
- - |
- - |
- - |
| 2011 | -19.72% 10/27 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 平安港股医疗优选股票(QDII)A | 0.9556 | 19.76% |
| 平安港股医疗优选股票(QDII)C | 0.9520 | 18.70% |
| 诺安油气能源 | 1.4510 | 13.79% |
| 创金合信全球医药生物股票发起(QDII)A | 1.5491 | 9.61% |
| 创金合信全球医药生物股票发起(QDII)C | 1.5285 | 9.47% |
| 宏利印度股票(QDII) | 1.3394 | 3.49% |
| 宏利印度股票(QDII)C | 1.3360 | 3.41% |
| 长城港股价值优选股票(QDII)A | 0.9773 | 1.91% |
| 长城港股价值优选股票(QDII)C | 0.9755 | 1.82% |
| 华宝海外科技股票(QDII-LOF)A | 2.3598 | 1.69% |
| 工银全球精选股票(QDII) VS. 华宝海外科技股票(QDII(501312) |